Rite Aid persists in developing COVID-19 testing sites with eleven different places opening Wednesday, April 22, in Delaware, Idaho, Michigan, New York, New Jersey, Ohio, Pennsylvania, and Virginia through its cooperation with the U.S. Department of Health and Human Services (HHS).
Nowadays spanning eight states and 24 store areas, all of Rite Aid’s self-testing sites will be open from 9 a.m.-5 p.m. seven days a week and require to be able to handle about 200 tests each day through online employment.
Generally, Rite Aid will have the ability to perform almost 5,000 tests daily across all areas.
New Rite Aid COVID-19 self-swab trial site places opening Wednesday, April 22:
- Albany, NY: 1863 Central Avenue in Colonie
- Akron, OH: 4053 South Main Street in Akron
- Youngstown, OH: 713 North State Street in Girard
- Erie, PA: 5430 Peach Street in Erie
- Scranton, PA: 20 South River Street in Plains
- Virginia Beach, VA: 2293 Upton Drive in Virginia Beach
- Dover, DE: 200 Pharmacy Drive in Smyrna
- Boise, ID: 3250 S. Eagle Road in Meridian
- Grand Rapids, MI: 5995 Kalamazoo Avenue, SE in Kentwood
- Saginaw, MI: 4598 State Street in Saginaw
- Central, NJ: 31 Mule Road in Toms River
All-Rite Aid drive-up COVID-19 testing areas will use self-swab nasal examinations overseen by Rite Aid pharmacologists. Testing qualification is based on guidelines set by the Centers for Disease Control and Prevention (CDC), which can be seen here.
The trial will take place in each store’s parking lot. As part of the trial process, people should continue in their vehicles from the time they come and until they leave.
Testing will be accessible at no cost to qualified people who meet the criteria set by the CDC. Patients are asked to show a government-issued permit, be at least 18 years old, and need to pre-register online at www.riteaid.com to register a time slot for testing.
Rite Aid has partnered with Verily and will use its Baseline COVID-19 Program to implement screening, scheduling, and results of proceeds to shareholders for Rite-Aid testing sites.
Rite Aid also decided BioReference Laboratories to give COVID-19 laboratory experiments to all drive-up areas to flatten the curve through available characteristic testing.
Clinical failure for the COVID-19 testing record is produced by PWNHealth, a national clinician network that allows safe and secure access to diagnostic testing.
Rite Aid will proceed to provide regular updates on the company’s expansion with the COVID-19 trial.
Rite Aid Corporation is on the front lines of delivering healthcare settings and direct results to more than 1.6 million Americans every day. Our pharmacologists are uniquely positioned to engage with consumers and improve their health consequences. We provide an array of the whole being health outcomes and services for the entire family through over 2,400 retail medicine locations across 18 states. Through EnvisionRxOptions, we offer pharmacy advantages and services to nearly 4 million members nationwide.